Updates in IDH-Wildtype Glioblastoma

被引：0

作者：

Jawad M. Melhem

Jay Detsky

Mary Jane Lim-Fat

James R. Perry

机构：

[1] Sunnybrook Health Sciences Centre,Division of Neurology, Department of Medicine, Faculty of Medicine

[2] University of Toronto,Department of Radiation Oncology

[3] Odette Cancer Centre,undefined

[4] Sunnybrook Health Sciences Centre,undefined

来源：

Neurotherapeutics | 2022年 / 19卷

关键词：

Glioblastoma; IDH-wildtype; Targeted therapy; Precision medicine; Clinical trials;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Glioblastoma is the most aggressive primary brain tumor with a poor prognosis. The 2021 WHO CNS5 classification has further stressed the importance of molecular signatures in diagnosis although therapeutic breakthroughs are still lacking. In this review article, updates on the current and novel therapies in IDH-wildtype GBM will be discussed.

引用

页码：1705 / 1723

页数：18

共 50 条

[1] Updates in IDH-Wildtype Glioblastoma
Melhem, Jawad M.
Detsky, Jay
Lim-Fat, Mary Jane
Perry, James R.
NEUROTHERAPEUTICS, 2022, 19 (06) : 1705 - 1723
[2] LONGITUDINAL EPIGENOMIC EVOLUTION OF IDH-WILDTYPE GLIOBLASTOMA
Al-Adli, Nadeem N.
Young, Jacob S.
Lucas, Calixto-Hope G.
Gupta, Rohit
Morshed, Ramin A.
Wu, Jasper
Ravindranathan, Ajay
Shai, Anny
Bush, Nancy Ann Oberheim
Taylor, Jennie W.
de Groot, John
Villanueva-Meyer, Javier
Pekmezci, Melike
Perry, Arie
Bollen, Andrew W.
Theodosopoulos, Philip, V
Aghi, Manish K.
Chang, Edward F.
Hervey-Jumper, Shawn L.
Raleigh, David R.
Diaz, Aaron A.
Costello, Joseph F.
Clarke, Jennifer L.
Butowski, Nicholas
Phillips, Joanna J.
Chang, Susan M.
Berger, Mitchel S.
Solomon, David A.
NEURO-ONCOLOGY, 2024, 26
[3] IDH-Mutant Or IDH-Wildtype? Unusual Subclonal IDH Mutation In A Glioblastoma
Martinez-Lage, Maria
Forst, Deborah
Jones, Pamela
Dias-Santagata, Dora
Lennerz, Jochen
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2018, 77 (06): : 492 - 492
[4] GLIOBLASTOMA, IDH-WILDTYPE WITHOUT KEY MOLECULAR FEATURES
Saito, Ryuta
Motomura, Kazuya
Ohka, Fumiharu
Yamaguchi, Junya
Maeda, Sachi
Nishikawa, Tomohide
Mizutani, Kosuke
Kibe, Yuji
Shimizu, Hiroki
Takido, Yuhei
NEURO-ONCOLOGY, 2023, 25
[5] The inverse paradigm and the ancestral cell of IDH-wildtype glioblastoma
Enrico Brognaro
Clinical and Translational Oncology, 2022, 24 : 13 - 23
[6] IDH-wildtype Glioblastoma with Microcalcifications - Clinical and Genomic Characterization
Umphlett, Melissa
Houldsworth, Jane
Fowkes, Mary
Tsankova, Nadejda
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2019, 78 (06): : 531 - 532
[7] Transformation of IDH-wildtype glioblastoma to gliosarcoma with features of osteosarcoma
Sobczyk, Pawel
Sobstyl, Michal
Acewicz, Albert
Rosa, Joanna
Grabiec, Marta
Grajkowska, Wieslawa
FOLIA NEUROPATHOLOGICA, 2024, 62 (01) : 96 - 101
[8] Impact of frailty on survival glioblastoma, IDH-wildtype patients
Hudelist, Benoit
Elia, Angela
Roux, Alexandre
Paun, Luca
Schumacher, Xavier
Hamza, Meissa
Demasi, Marco
Moiraghi, Alessandro
Dezamis, Edouard
Chretien, Fabrice
Benzakoun, Joseph
Oppenheim, Catherine
Zanello, Marc
Pallud, Johan
JOURNAL OF NEURO-ONCOLOGY, 2024, 169 (01) : 61 - 72
[9] The inverse paradigm and the ancestral cell of IDH-wildtype glioblastoma
Brognaro, Enrico
CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (01): : 13 - 23
[10] LONGITUDINAL MOLECULAR EVOLUTION OF IDH-WILDTYPE GLIOBLASTOMA IN ADULTS
Lucas, Calixto-Hope
Al-Adli, Nadeem
Young, Jacob
Morshed, Ramin
Gupta, Rohit
Wu, Jasper
Ravindranathan, Ajay
Lee, Julieann
Shai, Anny
Bush, Nancy Ann Oberheim
Taylor, Jennie
de Groot, John
Butowski, Nicholas
Pekmezci, Melike
Perry, Arie
Bollen, Andrew
Theodosopoulos, Philip
Aghi, Manish
Chang, Edward
Hervey-Jumper, Shawn
Costello, Joseph
Clarke, Jennifer
Diaz, Aaron
Phillips, Joanna
Berger, Mitchel
Chang, Susan
Solomon, David
NEURO-ONCOLOGY, 2023, 25

← 1 2 3 4 5 →